StockNews.com began coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a research report sent to investors on Saturday. The firm issued a hold rating on the software maker’s stock.
Separately, TD Cowen decreased their price objective on Veradigm from $26.00 to $15.00 and set a buy rating on the stock in a research report on Tuesday, May 28th. Four equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of Hold and a consensus price target of $12.00.
View Our Latest Research Report on MDRX
Veradigm Trading Up 1.0 %
Institutional Investors Weigh In On Veradigm
Several hedge funds and other institutional investors have recently modified their holdings of the business. Vanguard Group Inc. raised its holdings in shares of Veradigm by 0.7% in the fourth quarter. Vanguard Group Inc. now owns 14,275,875 shares of the software maker’s stock worth $149,754,000 after buying an additional 95,291 shares during the period. Wellington Management Group LLP boosted its position in Veradigm by 117.8% during the 4th quarter. Wellington Management Group LLP now owns 5,806,297 shares of the software maker’s stock valued at $60,908,000 after acquiring an additional 3,140,483 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its position in Veradigm by 8.9% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,087,605 shares of the software maker’s stock valued at $21,899,000 after acquiring an additional 171,199 shares in the last quarter. Goldman Sachs Group Inc. boosted its position in Veradigm by 6.6% during the 4th quarter. Goldman Sachs Group Inc. now owns 1,596,684 shares of the software maker’s stock valued at $16,749,000 after acquiring an additional 99,528 shares in the last quarter. Finally, Tyro Capital Management LLC bought a new stake in Veradigm during the 1st quarter valued at $9,055,000.
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Further Reading
- Five stocks we like better than Veradigm
- NYSE Stocks Give Investors a Variety of Quality OptionsĀ
- Palo Alto Analysts Drive it to New Highs: 50% Upside Is Possible
- Basic Materials Stocks Investing
- Roblox’s Growth Beyond Kids: Stock Set for Major Moves
- What is the Dow Jones Industrial Average (DJIA)?
- 5 Oversold Stocks to Buy Right Now
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.